In use for more than a century, inhaled anaesthetics like nitrous oxide and halothane have made modern surgery possible.
Now, in experiments in mice, researchers have found that certain so-called "volatile" anaesthetics - commonly used during surgeries - may also possess powerful effects on the immune system that can combat viral and bacterial infections in the lung, including influenza and pneumonia.
Researchers built their experiments on previous work showing that children with upper viral respiratory tract infections who were exposed to the anaesthetic halothane during minor surgical procedures had significantly less respiratory symptoms and a shorter duration of symptoms compared with children who did not receive halothane.
The team discovered that giving the animals volatile anaesthetics, such as halothane, led to decreased bacterial burden and lung injury following infection.
The researchers report that the anaesthetics augmented the anti-bacterial immune response after influenza viral infection by blocking chemical signalling that involves type I interferon, a group of proteins that help regulate the activity of the immune system.
The investigators report that symptoms of piloerection (involuntary bristling of hairs of the skin), hunched posture, impaired gait, laboured breathing, lethargy, and weight loss (equal to or greater than 10 per cent of body weight at the time of infection) were significantly less in mice exposed to halothane and then infected with flu and S pneumonia.
"Given that these drugs are the most common anaesthetics used in the operating room, there is a serious need to understand how they work and how we can use their immune effects to our advantage," said Chakravarthy.
The findings, he said, suggest that volatile anaesthetics may someday be helpful for combating seasonal and pandemic influenza, particularly when there are flu vaccine shortages or limitations.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
